SberMedAI

What SberMedAI does

SberMedAI (legal entity ООО «СберМедИИ», founded 2020) is a private Russian healthcare AI company operating within the Sber (Sberbank) ecosystem as part of Sber's health industry vertical. The company develops AI software and integrated medical equipment for diagnostic imaging analysis, clinical decision support, and patient triage. Its core offering is organized around the MDDC (Medical Digital Diagnostic Center) platform, which unifies a portfolio of more than a dozen registered AI services. Medical imaging products include CT brain stroke detection (КТ Инсульт), CT chest analysis covering 14 pathological features (КТ Грудной клетки), CT abdomen, chest X-ray, knee X-ray osteoarthritis, and mammography (lesion detection with BI-RADS classification and PGMI quality control). Text-analysis products include TOP-3 (preliminary diagnosis suggestions across 265 diagnosis groups), AIDA (final diagnosis prediction from electronic medical records, trained on 30 million patient visits), and OMS-Expert (automated compliance checking against insurance fund requirements). The Digital Assistant multi-agent system, powered by the GigaChat Russian-language LLM fine-tuned on over 60 GB of medical data, handles test interpretation, symptom collection, and pharmacology queries. Hardware-software products include the Digital FAP mobile diagnostic kit and the GigaDoc facial video-based health screening assistant using remote photoplethysmography.

Underlying technology is built on proprietary deep learning models trained on large Russian-language clinical datasets, co-developed with the Sberbank AI Laboratory and Skoltech. Models are registered with Roszdravnadzor as Class 3 risk medical devices and listed in the Russian Domestic Software Registry, providing regulatory barriers to entry. The TOP-3 product received the WSIS Prizes 2021 Champion award from the UN International Telecommunication Union.

SberMedAI generates revenue through B2G subscription licensing to public hospitals, polyclinics, and regional health ministries across 70+ Russian regions, with quote-based multi-year enterprise contracts. Revenue is supplemented by hardware sales of the Digital FAP and GigaDoc kits. Distribution leverages Sberbank's government relationships and alignment with federal programs including the Unified Digital Health Contour (ЕГИСЗ) and the national cardiovascular disease initiative. The company employs 51-100 people, has recorded over 86 million service invocations cumulatively, and supports active deployments in institutions ranging from Moscow polyclinics to remote regional hospitals in Primorsky Krai, Volgograd Oblast, Kurgan Oblast, and Magadan Oblast.

Name

SberMedAI

Legal name

ООО «СберМедИИ»

Website

https://sbermed.ai

Company type

Private

Founded year

2020

Operating status

Operating

Headcount range

11–50 employees

Short description

SberMedAI is a Russian healthcare AI company that develops medical imaging analysis, clinical decision-support software, and integrated diagnostic equipment for public hospitals and regional health ministries across 70+ Russian regions.

Ownership category

akta.pro rank

Product category

Healthcare AI Software / Medical Imaging AI

NAICS

Software Publishers (513210)

SIC

Services-Prepackaged Software (7372), Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

SaMD – Imaging & Signal Analysis (AI/ML) (HLACANAG)

akta.pro secondary industries

Medical Imaging AI (HDAAAEAH), AI Orchestration & Imaging Analytics Platforms (Model Management/Triage) (HLACALAG), iBPMS (Intelligent BPM Suites) & Process Automation Suites (HDAEAHAG)

Keywords

• AI medical imaging
• Healthcare AI solutions
• Clinical decision support
• Radiology AI software
• Medical image analysis

Headquarters

HQ city

Moscow

HQ country

Russia

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Software

Cost components

Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Healthcare AI Software Licensing: SberMedAI generates revenue through licensing its AI medical software products to healthcare institutions. Public medical institutions (polyclinics, hospitals, regional health departments) purchase or license these AI services, often through government procurement channels. Revenue is driven by multi-year contracts with regional health ministries and public healthcare networks across 70+ Russian regions. The company offers both direct deployment and integration with regional medical information systems (МИС/РМИС).
2. Medical Equipment Sales (Digital FAP and GigaDoc): Sale of hardware-software complexes including the Digital FAP mobile diagnostic kit and GigaDoc multimodal medical assistant. These are sold as integrated hardware/software packages to healthcare organizations, regional health departments, and educational institutions.

Pricing tiers

Go-to-market motion2 records

Distribution channels2 records

Marketing channels4 records

Core offering

SberMedAI develops and sells AI-based software products for medical image analysis and clinical decision support. Its portfolio includes AI tools that analyze CT scans, X-rays, and mammograms to detect pathologies such as lung cancer, COVID-19, stroke, and breast cancer, materially reducing radiology reading time. The company serves healthcare organizations and clinicians, with deployments across 70+ regions of the Russian Federation.

Product overview

SberMedAI is a healthcare AI company offering a multi-product portfolio organized as a platform-and-modules architecture. The core MDDC (Medical Digital Diagnostic Center) platform unifies multiple AI services. On the text-analysis side, ТОП-3 provides preliminary diagnosis suggestions from patient complaints (3 most probable diagnoses), AIDA suggests final diagnoses from electronic medical records (94 diagnoses), and ОМС-Эксперт performs automated insurance/clinical compliance checks on medical records. The 'Цифровой помощник' AI-agent system automates medical organization tasks via multiple skills (test interpretation, symptom collection, patient/physician assistance, pharmacology) using GigaChat fine-tuned on medical data. On the medical imaging side, the portfolio includes: КТ инсульт (CT brain for stroke), КТ грудной клетки (CT chest, 14 features), КТ брюшной полости (CT abdomen), Рентген грудной клетки (chest X-ray), Рентген коленного сустава (knee X-ray for osteoarthritis), and Маммография (mammography with BI-RADS and PGMI quality control) with a dedicated technical control module. The hardware layer includes Цифровой ФАП (mobile diagnostic kit with integrated AI) and GigaDoc (facial video-based health screening). The УДАР system integrates AI routing, teleconsultation, and CT analysis for stroke patient management. The company covers 70+ Russian regions, has processed 86M+ service calls, and addresses approximately 90% of the most common diseases.

Differentiator

Problem solved

Functional benefit

Brands

• MDDC (Medical Digital Diagnostic Center): Medical Digital Diagnostic Center — a platform combining AI services that help doctors make the most effective decisions, including AI-based medical image analysis and text data analysis.
• Digital Assistant (Цифровой помощник)
• Mammography. Technical Control (Маммография. Технический контроль)
• UDAR (УДАР)
• Gigadoc (Гигадок)
• Digital FAP (Цифровой ФАП)

Products and services

• CT AI Analysis

Quantifiable outcome

• Stroke mortality reduced by 36.5% in Primorsky Krai (2021–2024) with UDAR system deployment
• +13 more outcomes

Named customers13 records

Segments3 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

Yes

API docs

API detail

Core technology

AI maturity

App detail

Integration4 records

AI capability9 records

Feature13 records

Partnerships

Eight partnerships are on record, tiered core, flagship and minor.

• Sberbank AI Laboratory (Лаборатория искусственного интеллекта Сбера)coreTechnology or IntegrationSberMedAI collaborates with the Sberbank AI Laboratory on developing AI models for medical imaging analysis. The KT-Insult and CT-Chest services were co-developed by SberMedAI and the AI Laboratory, combining Sber's AI research capabilities with SberMedAI's medical domain expertise.
• Moscow Government (Правительство Москвы)flagshipStrategic or Co-development PartnerMoscow Government co-initiated and co-funded multiple SberMedAI product developments including TOP-3 and AIDA, working with SberMedAI's AI Laboratory. The TOP-3 service was developed under the Moscow Digital Economy program, and Moscow served as the first deployment site for multiple SberMedAI products.
• Almazov National Medical Research Center (НМИЦ им. В.А. Алмазова)coreStrategic or Co-development PartnerCo-developed the OMS-Expert AI service for medical record verification together with Almazov Center, leveraging clinical expertise in healthcare quality standards and regulatory compliance.
• Saratov State Medical University (СГМУ им. В.И. Разумовского)coreStrategic or Co-development PartnerJointly developed the knee X-ray osteoarthritis AI service with the Research Institute of Traumatology, Orthopedics and Neurosurgery of Saratov State Medical University. The university conducted clinical pilot testing validating accuracy metrics above 81%.
• NTI NeuroNet HealthNet Market (Рынок НТИ Хелснет)minorStrategic or Co-development PartnerSberMedAI joined the NTI NeuroNet HealthNet market in March 2023, participating in Russia's national technology initiative ecosystem for healthcare innovation.
• Innovation Agency of Moscow (Агентство инноваций Москвы)minorChannel Partner/ Reseller/ DistributorListed as a partner organization supporting SberMedAI's activities and market access within Moscow's innovation ecosystem for digital healthcare solutions.
• Moscow Healthcare Department (Департамент здравоохранения Москвы)flagshipStrategic or Co-development PartnerMoscow Healthcare Department collaborated on developing and validating TOP-3 and AIDA AI services. The department provided expert physician oversight and clinical validation for the AI models trained on Moscow's electronic medical record data.
• Digital Economy (Цифровая экономика)minorStrategic or Co-development PartnerListed as a partner supporting digital economy initiatives. The organization works with digital economy programs to advance AI deployment in Russian healthcare under national digital transformation strategies.

Scale indicators18 records

Recent moves6 records

Expansion highlights7 records

Broad incumbents

• Nanox AI (formerly Zebra Medical Vision): AI imaging suite now commercialized through Nanox's hardware-led platform, offering multi-modality AI analytics comparable in breadth to SberMedAI's CT/X-ray/mammography portfolio but bundled with imaging hardware globally.

Direct peers

• Care Mentor AI: Russian medical imaging AI vendor specializing in radiology AI (CT, X-ray, mammography) and listed as both partner and ecosystem peer in Moscow's AI healthcare programs. Competes head-to-head for regional tenders and inclusion in federal SaMD registries.
• Botkin.AI: Russian AI platform for medical imaging analysis (CT, X-ray, mammography) participating in the Moscow radiology AI experiment. Directly comparable to SberMedAI in product portfolio, target customers (public hospitals and regional health ministries), and Russian SaMD regulatory pathway.
• Celsus (Smart Health): Russian radiology AI platform (CT, X-ray, mammography) with Roszdravnadzor-registered products also participating in the Moscow radiology AI experiment. Targets the same regional health ministry procurement as SberMedAI.
• Viz.ai: US-based AI company whose flagship product is automated CT stroke detection and care coordination, directly comparable to SberMedAI's КТ-Инсульт and УДАР stroke management system in both clinical workflow and AI imaging approach.
• Aidoc: Global AI medical imaging platform providing suite-level triage and notification across CT and X-ray modalities. Comparable to SberMedAI's MDDC as a multi-modality imaging AI suite deployed at hospital-system scale.
• RapidAI: AI company focused on stroke and triage imaging, with products spanning CT perfusion, ASPECTS scoring, and care-coordination workflows. Highly comparable to SberMedAI's КТ-Инсульт (ASPECTS) and UDAR patient-management system.

Emerging players

• IRA Labs: Early-stage Russian medical AI startup focused on imaging and diagnostics; shown as a partner/ecosystem player on SberMedAI's site. Representative of the emerging cohort that could erode SberMedAI's regional share as Russian healthcare AI matures.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks7 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/SberMedAI
• LinkedInlinkedin.com/company/sbermedai

Compliance13 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about SberMedAI